It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The pathogenesis of Alzheimer’s disease (AD), a slowly-developing age-related neurodegenerative disorder, is a result of the action of multiple factors including deregulation of Ca2+ homeostasis, mitochondrial dysfunction, and dysproteostasis. Interaction of these factors in astrocytes, principal homeostatic cells in the central nervous system, is still poorly understood. Here we report that in immortalized hippocampal astrocytes from 3xTg-AD mice (3Tg-iAstro cells) bioenergetics is impaired, including reduced glycolysis and mitochondrial oxygen consumption, and increased production of reactive oxygen species. Shotgun proteomics analysis of mitochondria-ER-enriched fraction showed no alterations in the expression of mitochondrial and OxPhos proteins, while those related to the ER functions and protein synthesis were deregulated. Using ER- and mitochondria-targeted aequorin-based Ca2+ probe we show that, in 3Tg-iAstro cells, ER was overloaded with Ca2+ while Ca2+ uptake by mitochondria upon ATP stimulation was reduced. This was accompanied by the increase in short distance (≈8–10 nm) contact area between mitochondria and ER, upregulation of ER-stress/unfolded protein response genes Atf4, Atf6 and Herp, and reduction of global protein synthesis rate. We suggest that familial AD mutations in 3Tg-iAstro cells induce mitochondria-ER interaction changes that deregulate astrocytic bioenergetics, Ca2+ homeostasis and proteostasis. These factors may interact, creating a pathogenic loop compromising homeostatic and defensive functions of astroglial cells predisposing neurons to dysfunction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Università degli Studi del Piemonte Orientale, Department of Pharmaceutical Sciences, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
2 Lithuanian University of Health Sciences, Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Kaunas, Lithuania (GRID:grid.45083.3a) (ISNI:0000 0004 0432 6841)
3 University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
4 University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741); University of Piemonte Orientale, Center for Translational Research on Autoimmune and Allergic Diseases (CAAD), Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
5 University of Piemonte Orientale, Center for Translational Research on Autoimmune and Allergic Diseases (CAAD), Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741); University of Piemonte Orientale, Department of Health Science, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
6 DiSIT, University of Piemonte Orientale, Alessandria, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
7 Lithuanian University of Health Sciences, Department of Drug Chemistry, Faculty of Pharmacy, Medical Academy, Kaunas, Lithuania (GRID:grid.45083.3a) (ISNI:0000 0004 0432 6841)
8 University of Piemonte Orientale, Center for Translational Research on Autoimmune and Allergic Diseases (CAAD), Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741); University of Piemonte Orientale, Department of Health Science, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741); University of Piemonte Orientale, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)